Get a free sample of Antihypertensive Drugs Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Antihypertensive Drugs Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Antihypertensive Drugs Market Size
The global antihypertensive drugs market size valued at USD 23.9 billion in 2024 and is projected to exhibit 4.1% CAGR from 2025 to 2034. The market is growing due to growing prevalence of hypertension, advances in hypertensive drug development and formulations, growing awareness about the risks of hypertension, and integration of digital health solutions in treatment strategies.
Hypertension is a major global health issue, with a large portion of the population affected, especially in aging demographics. According to the World Health Organization, globally, approximately 1.28 billion adults aged 30 to 79 are living with hypertension. As the global population ages and lifestyles shift, hypertension rates continue to rise, creating a greater demand for antihypertensive medications. Moreover, with better healthcare infrastructure and awareness campaigns, more individuals are being diagnosed with hypertension. This is expected to contribute to an increasing number of patients seeking treatment, thus driving demand for antihypertensive drugs?.
Antihypertensive drugs are a class of drugs used to treat high blood pressure (hypertension). These medications help lower blood pressure by either relaxing the blood vessels or reducing the heart's workload, ultimately preventing complications such as stroke, heart attack, kidney damage, and other cardiovascular diseases.
Who are some of the prominent players in the antihypertensive drugs industry?
Key players in the market include AbbVie, AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Johnson & Johnson Services, Lupin, Merck & Co, Noden Pharma DAC, Novartis AG, Pfizer, and Sanofi.
How much is the North American antihypertensive drugs industry worth?
The U.S. led the North American antihypertensive drugs market in 2024, generating approximately USD 9 billion, attributed to the high prevalence of hypertension in the region.
Which segment dominates the antihypertensive drugs industry?
The diuretics segment held a 22.4% market share in 2024, primarily due to the significant adoption of thiazide diuretics for their proven efficacy in lowering blood pressure.
How big is the antihypertensive drugs market?
The global antihypertensive drugs industry was valued at USD 23.9 billion in 2024 and is projected to grow at a 4.1% CAGR from 2025 to 2034, driven by the rising prevalence of hypertension and advancements in drug formulations.